PATH
Menu

PATH will join an international gathering of scientists, clinicians, and health professionals at the 62nd annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) in Washington, DC, from November 13 to 17.

Malaria will be a key focus of the meeting, and PATH staff will highlight our innovative work on malaria prevention, elimination, diagnostics, treatment, vaccine development, and more.

The ASTMH is a worldwide organization representing researchers, program professionals, and others with interests in the prevention and control of tropical diseases through research and education.

Our featured work

During the conference, PATH staff will host or participate in the following events, sessions, symposia, and poster presentations focused on malaria. PATH staff will also present work on maternal health, meningitis, onchocerciasis, typhoid, and yellow fever.

Events

Daily

Each day of the conference, PATH and the ASTMH will host a live Twitter chat featuring malaria experts, including Dr. Carlos C. (Kent) Campbell, director of the Malaria Control Program at PATH.

November 12

The Malaria Control and Evaluation Partnership in Africa (MACEPA), a program at PATH, will participate in ASTMH Hill Day, meeting with representatives on Capitol Hill to make the case for tropical medicine research and funding.

PATH will coordinate a communicators and social media networking event to share best practices and ideas for social media and collaboration. 5:30 p.m. to 7:30 p.m. at the Lebanese Taverna, 2641 Connecticut Ave. NW.

November 13

PATH’s Diagnostics for Malaria Elimination Toward Eradication project will host a meeting with malaria experts to refine product specifications for next-generation diagnostics intended to address the needs of malaria elimination settings. 3 p.m. to 5 p.m. at the Marriott Hotel. This is a closed event.

November 15

PATH will host a congressional staff roundtable to provide an update on new tools and approaches in the fight against malaria, and the need for continued US government funding and political support. 10 a.m. to noon at the Congressional Visitors Center, Capitol Hill. Closed event.

PATH is cosponsoring a President’s Malaria Initiative reception to honor National Malaria Control Program officials and other key partners in the fight against malaria. 7 p.m. to 9 p.m. at the Marriott Hotel. Closed event.

Sessions

November 15

“Malaria: science and strategy—malaria operational research.” Cochair Duncan Earle, MACEPA. 10:15 a.m. to noon in Maryland AB.

  • Presentation: “Case investigation and reactive infection detection for malaria elimination in northern Senegal.” Duncan Earle, MACEPA. 10:15 a.m.
  • Presentation: “Spatio-temporal patterns associated with delivery of a mass screen and treatment campaign in southern Zambia: implications for modeling system parameters.” John Miller, MACEPA. 10:30 a.m.

“Malaria: elimination.” Cochair Kafula Silumbe, MACEPA. 10:15 a.m. to 12:05 p.m. in Marriott Ballroom Salon 1.

  • Presentation: “A 2012 demographic and seasonal profile of humans hosting the malaria parasite reservoir in Zambia: results from mass screen and treat (MSAT) activities in Southern Province and implications for elimination.” Kafula Silumbe, MACEPA. 10:50 a.m.

Symposia

November 14

“Establishing malaria-free zones in Zanzibar and Zambia: progress and next steps.” Symposium organizer Richard Steketee, Malaria Control Program at PATH. 8 a.m. to 9:45 a.m. in Marriott Ballroom Salon 2.

“No womb for Plasmodium: translating research into action to prevent malaria in pregnancy.” 7:15 p.m. to 9 p.m. in Marriott Ballroom Salon 3.

  • Presentation: “Where do we go from here: translating policy into action and developing a forward-thinking research and programmatic agenda.” Richard Steketee, Malaria Control Program at PATH. 8:15 p.m.

November 15

“Transmission-blocking vaccines for P. falciparum.” Symposium cochair David C. Kaslow, vice president of product development, PATH. 10:15 a.m. to noon in Marriott Ballroom Salon 2.

“Diagnostic strategies that support radical cure and elimination of vivax malaria.” Symposium organizer Paul LaBarre, senior technical officer, Technology Solutions Program, PATH. 4 p.m. to 5:45 p.m. in Marriott Ballroom Salon 2.

  • Presentation: “Head-to-head comparison of diagnostic tests for G6PD deficiency: supporting radical cure of P. vivax.” Gonzalo Domingo, Diagnostics Group, PATH. 5 p.m.

“Launch of the updated Malaria Vaccine Technology Roadmap: a global framework for development of vaccines to support malaria elimination and disease control.” 7:15 p.m. in Marriott Hotel Ballroom Salon 3. Symposium with reception.

  • Presentation: “MVI’s portfolio and strategy, and alignment with the updated roadmap.” Ashley Birkett, director, PATH Malaria Vaccine Initiative. 7:30 p.m.

November 16

“New strategies and tools targeting malaria transmission.” 8 a.m. to 9:45 a.m. in Marriott Ballroom Salon 1.

  • Presentation: “Transmission-blocking vaccines: the approach and new strategies.” Ashley Birkett, PATH Malaria Vaccine Initiative. 8:40 a.m. 

“Implementation of mass drug administration for malaria control and elimination.” 10:15 a.m to 12:15 pm in Marriott Ballroom Salon 2.

  • Presentation: “The challenges of screening and treatment campaigns.” John Miller, MACEPA. 11:30 a.m.

“Differential roles of efficacy and public health impact in assessing vaccines.” Symposium organizer David C. Kaslow, PATH. 4 p.m. to 5:45 p.m. in Thurgood Marshall North.

Poster presentations

November 16

Poster Session C. Noon to 1:45 p.m. in Exhibit Hall B/C

“Documenting malaria case management coverage in Zambia with a systems effectiveness approach.” Megan Littrell, John M. Miller, Micky Ndhlovu, Busiku Hamainza, Chibesa Wamulume, Davidson H. Hamer, and Richard W. Steketee.

“Evaluation of Zambia district health officer use of malaria rapid reporting data.” Marie-Reine I. Rutagwera, John M. Miller, Megan Littrell, Chris Lungu, Jason P. Pickering, Mercy Mwanza, and Mulakwa Kamuliwo.      

“Steps to malaria elimination in Amhara National Regional State, Ethiopia: The Malaria Elimination Demonstration Project.” Belay Bezabih, Asefaw Getachew, Belendia Adbissa, Megan Littrell, Berhane Haileselassie, Catherine Seneviratne, Tsehaye Tewabe, Eshetu Sata, Niway Hiruy, Gregory S. Noland, Duncan Earle, Zerihun Tadesse, Hiwot Solomon, Anatoly Frolov, and Richard W. Steketee.

“Using outcome-driven innovation theory to clarify target product profiles for next-generation malaria diagnostics.” Kathleen Tietje, Christine Clerk, Kenneth Hawkins, Sarah McGray, and Paul LaBarre.

“Evaluation of diagnostic platforms for G6PD deficiency, including two quantitative tests, the fluorescent spot test, a point-of-care test, and a cytochemical staining-based assay.” Nicole LaRue, Maria Kahn, Michael Kalnoky, Brandon T. Leader, Pooja Bansil, Sarah McGray, and Gonzalo J. Domingo.

More information